Clinical trials are conducted on a smaller population under controlled conditions. But once the drug is marketed it is used by millions of people across the globe. Pharmacovigilance plays the main role in developing a better knowledge of the benefits and risks of the drugs that are approved for marketing. Pharmacovigilance is mainly concerned with identifying, validating, quantifying, evaluating and minimizing the adverse drug reactions and adverse effects of drugs thereby improving their safety profile. Pharmacovigilance is related to safety profile of drugs whereas clinical research includes all areas of health issues and problems in a larger perspective. Pharmacovigilance  experts are required to identify all these safety aspects.

Pharmacovigilance is still at the beginning stage in India. There is an urgent need to understand
the importance and the impact of this field on the life cycle of the drug in the trial or already in
market. 

The Advanced Post Graduate Diploma in Clinical Research and Pharmacovigilance at James Lind Institute is an industry oriented program, providing the industry with a skilled pharmacovigilance professionals.

This program helps in cultivating the pharmacovigilance practice in daily life and trains candidates about the ethical and regulatory compliance required. It also provides knowledge about enhancing the clinical trial safety and post market surveillance. The objective of the course is to provide a complete knowledge of the clinical trials and Pharmacovigilance. The program is divided into two parts: first part provides the complete understanding to the clinical research field and the later part focuses on the processes involved in pharmacovigilance. The program is available on an online platform and can be completed in 6-8 months.

 Duration :- 6-8 months